Bioactive barrier

Binodal curves, 20 320-321 Bins concept, 70 32 Bioaccumulation, of herbicides, 73 310 Bioactive barrier, defined, 3 758t Bioactive fixation, 72 611 Bioactive food ingredients, 7 7 646 Bioactive nutritions, 7 7 645t Bioactive substances identifying, 77 646 safety of, 77 647 Bioactive zone, defined, 3 758t Bioadhesive agents, 9 48, 49 Bioadhesive drug delivery systems, 9 45... 

Other clinical studies have been focused on the artificial tympanic membrane application, ventilation mbes, an adhesion Barrier, elastic bioactive coatings on load-bearing dental and hip implants, and also for wound healing purposes. ... 

Poduslo JF, Curran GL, Gill JS. Pu-trescine-modified nerve growth factor bioactivity, plasma pharmacokinetics, blood-brain/nerve barrier permeability and nervous system biodistribution. 

Moreover,bioactive lipids maybe considered dual messengers they modulate cell functions as messengers and they become part of the response of the nervous tissue to injury, broadly referred to as the inflammatory response. This response occurs in ischemia-reperfusion damage associated with stroke, various forms of neurotrauma, infectious diseases and neurodegenerative diseases such as Alzheimer s disease. Inflammation in the nervous system differs from that in other tissues. If the blood-brain barrier is broken, blood-borne inflammatory cells (e.g. polymorphonuclear leukocytes, monocytes, macrophages) invade the intercellular space and glial cells are activated, particularly microglia, which play a prominent role in the inflammatory response. These responses may... 

Due to their highly biocompatible nature, dendritic PGs have a broad range of potential applications in medicine and pharmacology. The versatility of the polyglycerol scaffolds for application in the biomedical field has recently been reviewed [131], and a number of examples were described, therein, e.g., smart and stimuli-responsive delivery and release of bioactive molecules, enhanced solubilization of hydrophobic compounds, surface-modification and regenerative therapy, as well as transport of active agents across biological barriers (cell-membranes, tumor tissue, etc.). 

Ke, T. L., Graff, G., Spellman, J. M., and Yanni, J. M., Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation II. In vitro bioactivation and permeation of external ocular barriers. Inflammation 24(4) 371-384, 2000. 

Based on the earlier work of Meyer and Overton, who showed that the narcotic effect of anesthetics was related to their oil/water partition coefficients, Hansch and his co-workers have demonstrated unequivocally the importance of hydrophobic parameters such as log P (where P is, usually, the octanol/water partition coefficient) in QSAR analysis.28 The so-called classical QSAR approach, pioneered by Hansch, involves stepwise multiple regression analysis (MRA) in the generation of activity correlations with structural descriptors, such as physicochemical parameters (log P, molar refractivity, etc.) or substituent constants such as ir, a, and Es (where these represent hydrophobic, electronic, and steric effects, respectively). The Hansch approach has been very successful in accurately predicting effects in many biological systems, some of which have been subsequently rationalized by inspection of the three-dimensional structures of receptor proteins.28 The use of log P (and its associated substituent parameter, tr) is very important in toxicity,29-32 as well as in other forms of bioactivity, because of the role of hydrophobicity in molecular transport across cell membranes and other biological barriers. 

Higher plants are sessile and are consumed by motile organisms, namely other eukaryotes and prokaryotes. Plants defend themselves by physical barriers including cell walls at the cellular level, by the waxy cuticle of leaves and by bark and thorns at the macroscopic level. Plants also defend themselves from fungal and bacterial pathogens and animal herbivores by elaborating a variety of bioactive secondary metabolites and defensive proteins. There may be as many as 100,000 different kinds of plant defensive compounds of which about 30,000 have been isolated and structurally characterized. Biochemical targets have been determined in vitro or in vivo for some thousands of the defensive compounds isolated to date. 

Lastly we examine attempts to design structures for particular functions, namely, films that act as barriers and capsules that contain bioactive substances. In the future, we will need to create novelty in the long-term stability of products and delivery of specific molecules for a health benefit. These technologies are attracting attention not only from the food industry but also for nonfood use. Sustainable and environmentally friendly attributes of biomaterials are increasingly discussed, compared to petrochemically derived, synthetic polymers and plastics. For once, food materials scientists can teach other industries the rules of the game. ... 

In the foregoing sections, pharmacon metabolism has been considered in relation to the pharmacodynamic, especially toxic aspects of action. Drug distribution also plays a role in the pharmacodynamic phase of drug action. Modulation of drug distribution, for instance, exclusion of penetration of particular barriers in the organism (e.g. the blood-brain barrier), or preferential bioactivation or bioinactivation in particular tissues, can modulate the spectrum of action of compounds and possibly exclude particular undesired effects. 

---